← Eichor
Study identifier: NCT06950788 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Condition: Cirrhosis, Liver · Diabetes Mellitus Risk · Transplant; Failure, Liver  ·  Sponsor: University of Chicago

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced measurements such as wrist actigraphy, continuous glucose monitoring, or oral glucose tolerance testing predict the development of diabetes after liver transplant? Participants will be asked to periodically participate in wearing a continuous glucose monitor and wrist actigraph and obtain an oral glucose tolerance test both before and after liver transplant.

This description comes directly from the study's public registry record.

Talk to the study team

Alan L Hutchison, MD PhD  ·  773-702-1000  ·  Alan.Hutchison@uchicagomedicine.org

Mary E Rinella, MD  ·  773-702-1000  ·  mrinella@bsd.uchicago.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Chicago Medical CenterChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06950788